Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

The RSV vaccine contains a protein from the respiratory syncytial virus. When administered, it triggers the immune system to respond, creating protection that helps stave off severe infection.

What if infections of respiratory syncytial virus, known as R.S.V., peak at unusual levels, as they did in the 2022-23 season? What if the new strain of mpox, which is especially virulent ...

18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV ... risk of severe illness when the infection spreads to the lower respiratory ...

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...

Walsh, E. (n.d). National Library of Medicine. Respiratory Syncytial Virus infection in elderly adults. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16038573/ 8 Centers for Disease Control and ...

as the presentation is indistinguishable from other respiratory tract infections, and epidemics often overlap. The microbiologic confirmation of RSV infection is based on detecting the virus in a ...